Zurich, Switzerland
Medical Affairs professional with over a decade of experience in Medical Information, Medical/Scientific Communication, and Medical Strategy on Global and Regional levels, in small biotech as well as big pharma in pre-, peri-, and post launch phase. Strategic communicator, enthusiastic team player, supportive and collaborative mentor, always with the end goal in mind: getting the right treatment to the right patient.
• Led launch readiness activities for Rare Bleeding Disorders and Rare Endocrine Disorders, ensuring successful new product launches. • Co-developed insights framework in Rare Disease area, driving change management for actionable insights. • Optimized scientific communications approach through strong relationships with cross-functional colleagues.
• Led cross-functional teams to develop and execute international medical communications plans, ensuring activities were on time and within budget. • Organized scientific advisory boards, investigator meetings, and congress-related activities to engage key opinion leaders and drive awareness. • Managed and coached a team in international Medical Affairs, overseeing publications and medical communications activities.
Shire (acquired by Takeda in 2019) • Developed and executed multi-year Global Medical strategy for ADHD and Intuniv, driving scientific advisory boards and congress activities. • Provided Medical review to Global Regulatory, promotional, and non-promotional materials, ensuring compliance and accuracy. • Represented Medical Affairs at internal and external meetings, presenting ADHD and guanfacine medical and clinical data.
• Developed and communicated timely responses to medical information requests in EMEA. • Planned and executed congress materials for medical information. • Created monthly and quarterly reports for Medical Affairs stakeholders. • Managed compliant delivery of vendor services and trained colleagues on relevant processes.